We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+14.16%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$56.4B
AUM Growth
-$2.76B
(-4.7%)
Cap. Flow
-$9.06B
Cap. Flow
% of AUM
-16.06%
Top 10 Holdings %
Top 10 Hldgs %
19.21%
Holding
2,327
New
157
Increased
700
Reduced
1,279
Closed
151
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$128M |
| 2 |
FedEx
FDX
|
+$120M |
| 3 |
Peloton Interactive
PTON
|
+$97.8M |
| 4 |
Newmont
NEM
|
+$78.9M |
| 5 |
Infosys
INFY
|
+$78.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$291M |
| 3 |
Apple
AAPL
|
+$261M |
| 4 |
Microsoft
MSFT
|
+$240M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.67% |
| 2 | Healthcare | 15.33% |
| 3 | Consumer Discretionary | 14.73% |
| 4 | Consumer Staples | 10.36% |
| 5 | Industrials | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
2001
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $271K | ﹤0.01% |
6,313
+339
| +6% | +$16.7K |
|
2002
American Vanguard Corp
AVD
$64.4M
| $270K | ﹤0.01% |
17,426
+3,662
| +27% | +$54K |
|
2003
Liquidia Corp
LQDA
$8.06B
| $268K | ﹤0.01% |
90,801
+72,382
| +393% | +$266K |
|
|
RPAI
2004
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $268K | ﹤0.01% |
31,353
-110,112
| -78% | -$804K |
|
2005
Arbor Realty Trust
ABR
$1.01B
| $267K | ﹤0.01% |
18,802
| – | – |
|
|
ALLK
2006
DELISTED
Allakos
ALLK
| $266K | ﹤0.01% |
1,901
-9,082
| -83% | -$945K |
|
2007
RE/MAX Holdings
RMAX
$246M
| $265K | ﹤0.01% |
7,291
-2,191
| -23% | -$74.6K |
|
2008
Albany International
AIN
$1.76B
| $264K | ﹤0.01% |
3,597
-3,120
| -46% | -$197K |
|
|
BRKL
2009
DELISTED
Brookline Bancorp
BRKL
| $264K | ﹤0.01% |
21,926
+6,694
| +44% | +$72.4K |
|
2010
Glacier Bancorp
GBCI
$6.36B
| $264K | ﹤0.01% |
5,805
-9,006
| -61% | -$364K |
|
2011
Four Corners Property Trust
FCPT
$2.69B
| $261K | ﹤0.01% |
+8,768
| New | +$246K |
|
2012
Cleveland-Cliffs
CLF
$7.25B
| $260K | ﹤0.01% |
+17,877
| New | +$181K |
|
2013
SM Energy
SM
$7.59B
| $260K | ﹤0.01% |
42,435
-112,200
| -73% | -$378K |
|
2014
Vornado Realty Trust
VNO
$7.21B
| $260K | ﹤0.01% |
7,240
+65
| +0.9% | +$2.37K |
|
|
ATXS
2015
DELISTED
Astria Therapeutics
ATXS
| $259K | ﹤0.01% |
+20,140
| New | +$359K |
|
2016
Macy's
M
$6.47B
| $259K | ﹤0.01% |
23,060
-200,379
| -90% | -$1.71M |
|
|
IPHI
2017
DELISTED
INPHI CORPORATION
IPHI
| $258K | ﹤0.01% |
1,608
-9,511
| -86% | -$1.34M |
|
2018
SouthState Bank Corp
SSB
$10.5B
| $254K | ﹤0.01% |
3,514
-7,540
| -68% | -$495K |
|
2019
i3 Verticals
IIIV
$329M
| $252K | ﹤0.01% |
7,600
-1,351
| -15% | -$36.2K |
|
|
RAVN
2020
DELISTED
Raven Industries Inc
RAVN
| $252K | ﹤0.01% |
+7,610
| New | +$200K |
|
|
ORBC
2021
DELISTED
ORBCOMM, Inc.
ORBC
| $252K | ﹤0.01% |
33,944
+11,721
| +53% | +$63.3K |
|
|
AUD
2022
DELISTED
Audacy, Inc.
AUD
| $251K | ﹤0.01% |
101,511
-292,595
| -74% | -$598K |
|
2023
Regenxbio
RGNX
$680M
| $250K | ﹤0.01% |
5,508
-9,286
| -63% | -$324K |
|
2024
Triumph Financial Inc
TFIN
$1.81B
| $250K | ﹤0.01% |
+5,144
| New | +$232K |
|
2025
WesBanco
WSBC
$4.01B
| $250K | ﹤0.01% |
8,335
-2,621
| -24% | -$70.7K |
|
Similar funds
VGA
AQR Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, AQR Capital Management held 2,327 positions worth $56.4B, down 4.7% from $59.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
AQR Capital Management withdrew a net $9.06B in Q4 2020, closing 151 positions and reducing 1,279 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $291M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, AQR Capital Management opened a new position in Peloton Interactive worth $122M.
- AQR Capital Management's largest Q4 2020 buy was Peloton Interactive: 803,242 shares worth $122M.
- AQR Capital Management added most to Zoom in Q4 2020, an estimated $128M increase.
- AQR Capital Management's biggest Q4 2020 reduction was Biogen, cutting an estimated $309M.
- AQR Capital Management fully exited iShares Core S&P 500 ETF in Q4 2020, selling an estimated $291M.
- AQR Capital Management's ten largest holdings make up 19% of its $56.4B portfolio in Q4 2020.
- AQR Capital Management opened 157 new positions and closed 151 in Q4 2020.
- AQR Capital Management's portfolio value fell 4.7% quarter-over-quarter to $56.4B.
Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.